GlycoMimetics Inc. (GLYC) posted a $15.6 million loss in the fourth quarter on Tuesday.
The company, based in Rockville, Maryland, posted a loss of 32 cents per share.
The findings were as predicted by Wall Street. A loss of 32 cents per share was also expected by five analysts polled by Zacks Investment Research.
During that time, the biotechnology business gained $163,000 in sales.
The company’s loss for the year was estimated to be $51 million, or $1.12 per share. $10.2 million in revenue was registered.
The company’s stock finished the day at $3.59. They were trading at $3.49 a year ago.
